Bain Capital Public Equity Management’s Exelixis EXEL Stock Holding History

Bain Capital Public Equity Management’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-74,802	Closed	-$1.66M	–	74
2018 Q1	$1.66M	Buy	+74,802	New	+$2.07M	0.12%	52

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bain Capital Public Equity Management's EXEL Position: Q2 2018 in Review

Bain Capital Public Equity Management sold out of Exelixis (EXEL) in Q2 2018, closing a stake of 74,802 shares — an estimated $1.66M sold.

Bain Capital Public Equity Management first reported a position in EXEL in Q1 2018 and held it in 1 quarter. The position peaked at $1.66M in Q1 2018. 303 funds tracked by Wall St. Rank hold EXEL as of Q2 2018.

Bain Capital Public Equity Management reported no remaining Exelixis position as of Q2 2018 after selling out during the quarter.
Bain Capital Public Equity Management sold 74,802 Exelixis shares in Q2 2018, an estimated $1.66M.
Bain Capital Public Equity Management first reported a position in Exelixis in Q1 2018 and held it in 1 quarter.
Bain Capital Public Equity Management's Exelixis position peaked at $1.66M in Q1 2018.
303 funds tracked by Wall St. Rank held Exelixis as of Q2 2018.

Based on Bain Capital Public Equity Management's 13F filing for Q2 2018, filed 14 Aug 2018.